Menu
GeneBe

3-141487109-C-T

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006506.5(RASA2):​c.26C>T​(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00595 in 1,408,594 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A9S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0041 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 26 hom. )

Consequence

RASA2
NM_006506.5 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.103
Variant links:
Genes affected
RASA2 (HGNC:9872): (RAS p21 protein activator 2) The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004125297).
BP6
Variant 3-141487109-C-T is Benign according to our data. Variant chr3-141487109-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 929175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-141487109-C-T is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RASA2NM_006506.5 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant 1/24 ENST00000286364.9
RASA2NM_001303246.3 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant 1/25
RASA2NM_001303245.3 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant 1/24
RASA2XM_047448652.1 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant 1/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RASA2ENST00000286364.9 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant 1/241 NM_006506.5 P1Q15283-2
RASA2ENST00000515549.1 linkuse as main transcriptc.26C>T p.Ala9Val missense_variant, NMD_transcript_variant 1/54

Frequencies

GnomAD3 genomes
AF:
0.00416
AC:
626
AN:
150486
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00489
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000802
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00706
Gnomad OTH
AF:
0.00435
GnomAD3 exomes
AF:
0.00405
AC:
370
AN:
91248
Hom.:
4
AF XY:
0.00433
AC XY:
223
AN XY:
51508
show subpopulations
Gnomad AFR exome
AF:
0.00112
Gnomad AMR exome
AF:
0.00163
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000933
Gnomad FIN exome
AF:
0.00223
Gnomad NFE exome
AF:
0.00876
Gnomad OTH exome
AF:
0.00274
GnomAD4 exome
AF:
0.00616
AC:
7752
AN:
1258000
Hom.:
26
Cov.:
31
AF XY:
0.00602
AC XY:
3730
AN XY:
620074
show subpopulations
Gnomad4 AFR exome
AF:
0.000815
Gnomad4 AMR exome
AF:
0.00201
Gnomad4 ASJ exome
AF:
0.000100
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000729
Gnomad4 FIN exome
AF:
0.00299
Gnomad4 NFE exome
AF:
0.00726
Gnomad4 OTH exome
AF:
0.00476
GnomAD4 genome
AF:
0.00414
AC:
624
AN:
150594
Hom.:
6
Cov.:
32
AF XY:
0.00392
AC XY:
288
AN XY:
73554
show subpopulations
Gnomad4 AFR
AF:
0.00128
Gnomad4 AMR
AF:
0.00489
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.000802
Gnomad4 NFE
AF:
0.00706
Gnomad4 OTH
AF:
0.00431
Alfa
AF:
0.00571
Hom.:
1
Bravo
AF:
0.00417
ESP6500AA
AF:
0.00145
AC:
4
ESP6500EA
AF:
0.00265
AC:
16
ExAC
AF:
0.00238
AC:
246

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingInvitaeJan 25, 2024- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 30, 2019- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024RASA2: BS2 -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 01, 2023- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 26, 2019Variant summary: RASA2 c.26C>T (p.Ala9Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0041 in 91248 control chromosomes in the gnomAD database, including 4 homozygotes. The observed variant frequency is approximately 811 fold of the estimated maximal expected allele frequency for a pathogenic variant in RASA2 causing Noonan Syndrome and Related Conditions phenotype (5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.26C>T in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 09, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
RASA2-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesDec 14, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
18
DANN
Benign
0.96
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.0041
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
0.060
N;N
REVEL
Benign
0.059
Sift
Benign
0.55
T;T
Sift4G
Pathogenic
0.0
D;D
Vest4
0.29
MVP
0.55
MPC
0.34
ClinPred
0.034
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.0
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200191034; hg19: chr3-141205951; COSMIC: COSV53941630; API